Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Erion

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991
Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitorsS E Ealick, Y S Babu, C E Bugg, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1995
Structure-based design of inhibitors of purine nucleoside phosphorylaseY S Babu, S E Ealick, C E Bugg, et al.
Journal of Medicinal Chemistry|February 18, 1994
N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitorsS De Lombaert, M D Erion, J Tan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Adenosine kinase inhibitors as a novel approach to anticonvulsant therapyJ B Wiesner, B G Ugarkar, A J Castellino, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptideP P Tamburini, J A Koehn, J P Gilligan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectinsG S Firestein, D A Bullough, M D Erion, et al.
Journal of Medicinal Chemistry|January 8, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanineJ A Montgomery, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|June 25, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanineJ A Secrist, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|November 26, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene groupM D Erion, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|April 15, 1994
Structure-based design of inhibitors of purine nucleoside phosphorylase. 4. A study of phosphate mimicsW C Guida, R D Elliott, H J Thomas, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991
Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitorsS E Ealick, Y S Babu, C E Bugg, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1995
Structure-based design of inhibitors of purine nucleoside phosphorylaseY S Babu, S E Ealick, C E Bugg, et al.
Journal of Medicinal Chemistry|February 18, 1994
N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitorsS De Lombaert, M D Erion, J Tan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Adenosine kinase inhibitors as a novel approach to anticonvulsant therapyJ B Wiesner, B G Ugarkar, A J Castellino, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptideP P Tamburini, J A Koehn, J P Gilligan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectinsG S Firestein, D A Bullough, M D Erion, et al.
Journal of Medicinal Chemistry|January 8, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanineJ A Montgomery, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|June 25, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanineJ A Secrist, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|November 26, 1993
Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene groupM D Erion, S Niwas, J D Rose, et al.
Journal of Medicinal Chemistry|April 15, 1994
Structure-based design of inhibitors of purine nucleoside phosphorylase. 4. A study of phosphate mimicsW C Guida, R D Elliott, H J Thomas, et al.
Pageof 5